Nvidia-Backed Biotech Iambic Up 18% After $150 Million IPO
Iambic Therapeutics Inc. climbed 18% in its trading debut after the clinical-stage cancer drugmaker and technology firm raised $150 million in a US initial public offering.
This is a summary aggregated from Bloomberg Markets. Read the complete article on the original site:
Read full article at Bloomberg Markets
